NU Skin Enterprises Inc NUS.N, NUS is expected to show a fall in quarterly revenue when it reports results on February 13 for the period ending December 31 2024
The Provo Utah-based company is expected to report a 10.8% decrease in revenue to $435.989 million from $488.64 million a year ago, according to the mean estimate from 3 analysts, based on LSEG data.The company's guidance on November 7 2024, for the period ended December 31, was for revenue between $410.00 million and $445.00 million.
LSEG's mean analyst estimate for NU Skin Enterprises Inc is for earnings of 22 cents per share. The company's EPS guidance on November 7 2024, for the period ended December 31, was between $0.19 and $0.29
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is no "strong buy" or "buy," 3 "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for NU Skin Enterprises Inc is $7.00, above its last closing price of $6.47.
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER ENDING | STARMINESMARTESTIMATE® | LSEG IBES ESTIMATE | ACTUAL | BEAT, MET, MISSED | SURPRISE % |
Sep. 30 2024 | 0.19 | 0.20 | 0.17 | Missed | -13 |
Jun. 30 2024 | 0.17 | 0.17 | 0.21 | Beat | 25.5 |
Mar. 31 2024 | 0.05 | 0.05 | 0.09 | Beat | 76.5 |
Dec. 31 2023 | 0.28 | 0.28 | 0.37 | Beat | 29.9 |
Sep. 30 2023 | 0.62 | 0.62 | 0.56 | Missed | -10.3 |
Jun. 30 2023 | 0.53 | 0.53 | 0.54 | Beat | 1.3 |
Mar. 31 2023 | 0.33 | 0.33 | 0.37 | Beat | 12.2 |
Dec. 31 2022 | 0.53 | 0.53 | 0.89 | Beat | 66.4 |
This summary was machine generated February 11 at 21:37 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。